Fundamentals
| Year Ending Dec 2019 (Update) | Year Ending Dec 2018 (Update) | Year Ending Dec 2017 (Update) | Year Ending Dec 2016 (Restated) | |
|---|---|---|---|---|
| Net Sales | 4,757.06 | 4,262.89 | 3,307.24 | 3,139.88 |
| Revenue | 4,757.06 | 4,262.89 | 3,307.24 | 3,139.88 |
| Total Revenue | 4,757.06 | 4,262.89 | 3,307.24 | 3,139.88 |
| Cost of Revenue | 1,127.42 | 911.15 | 651.01 | 755.73 |
| Cost of Revenue, Total | 1,127.42 | 911.15 | 651.01 | 755.73 |
| Gross Profit | 3,629.64 | 3,351.75 | 2,656.23 | 2,384.15 |
| Selling/General/Administrative Expense | 2,329.98 | 2,097.07 | 1,876.20 | 1,694.39 |
| Labor & Related Expense | 188.60 | 196.45 | 224.28 | 83.15 |
| Selling/General/Administrative Expenses, Total | 2,518.57 | 2,293.52 | 2,100.48 | 1,777.54 |
| Research & Development | 345.42 | 309.33 | 250.88 | 212.77 |
| Depreciation | 88.40 | 75.36 | 74.27 | 71.68 |
| Amortization of Intangibles, Operating | 92.60 | 79.60 | 42.14 | 79.43 |
| Depreciation/Amortization | 180.99 | 154.96 | 116.41 | 151.10 |
| Impairment-Assets Held for Use | 3.32 | 28.80 | 0.00 | 275.37 |
| Impairment-Assets Held for Sale | -- | -- | 12.20 | 10.70 |
| Other Unusual Expense (Income) | -- | -120.60 | -- | -- |
| Unusual Expense (Income) | 3.32 | -91.80 | 12.20 | 286.07 |
| Total Operating Expense | 4,175.72 | 3,577.15 | 3,130.97 | 3,183.21 |
| Operating Income | 581.33 | 685.74 | 176.27 | -43.33 |
| Interest Expense - Non-Operating | -153.56 | -109.33 | -105.30 | -109.11 |
| Interest Expense, Net Non-Operating | -153.56 | -109.33 | -105.30 | -109.11 |
| Interest Income, Non-Operating | -- | 30.40 | 11.40 | 5.10 |
| Investment Income, Non-Operating | -- | 157.40 | 51.70 | 38.00 |
| Interest/Investment Income, Non-Operating | -- | 187.80 | 63.10 | 43.10 |
| Interest Income (Expense), Net-Non-Operating, Total | -153.56 | 78.47 | -42.20 | -66.01 |
| Gain (Loss) on Sale of Assets | -- | -- | -- | -- |
| Other Non-Operating Income (Expense) | 66.74 | -2.65 | -67.11 | 28.25 |
| Other, Net | 66.74 | -2.65 | -67.11 | 28.25 |
| Net Income Before Taxes | 494.51 | 761.56 | 66.96 | -81.09 |
| Income Tax – Total | -49.31 | 13.00 | -353.75 | -64.93 |
| Income After Tax | 543.82 | 748.56 | 420.71 | -16.15 |
| Minority Interest | -112.69 | -130.79 | -53.08 | -25.13 |
| Net Income Before Extraordinary Items | 431.13 | 617.77 | 367.62 | -41.28 |
| Discontinued Operations | -- | -- | -- | -- |
| Extraordinary Item | -- | 9.19 | -62.70 | -- |
| Total Extraordinary Items | -- | 9.19 | -62.70 | -- |
| Net Income | 431.13 | 626.96 | 304.92 | -41.28 |
| Income Available to Common Excluding Extraordinary Items | 431.13 | 617.77 | 367.62 | -41.28 |
| Income Available to Common Stocks Including Extraordinary Items | 431.13 | 626.96 | 304.92 | -41.28 |
| Basic Weighted Average Shares | 84.21 | 83.41 | 80.09 | 80.05 |
| Basic EPS Excluding Extraordinary Items | 5.12 | 7.41 | 4.59 | -0.52 |
| Basic EPS Including Extraordinary Items | 5.12 | 7.52 | 3.81 | -0.52 |
| Dilution Adjustment | -- | -- | -- | -- |
| Diluted Net Income | 431.13 | 626.96 | 304.92 | -41.28 |
| Diluted Weighted Average Shares | 95.81 | 91.32 | 85.31 | 80.05 |
| Diluted EPS Excluding Extraordinary Items | 4.50 | 6.76 | 4.31 | -0.52 |
| Diluted EPS Including Extraordinary Items | 4.50 | 6.87 | 3.57 | -0.52 |
| DPS - Common Stock Primary Issue | -- | -- | -- | -- |
| Dividend per Share – Common Stock Issue 2 | -- | -- | -- | 0.00 |
| Gross Dividends - Common Stock | -- | 0.00 | 0.00 | 0.00 |
| Other Unusual Expense (Income), Supplemental | -- | -- | -- | -- |
| Non-Recurring Items, Total | -- | -- | -- | -- |
| Total Special Items | 3.32 | -91.80 | 12.20 | 286.07 |
| Normalized Income Before Taxes | 497.83 | 669.76 | 79.16 | 204.98 |
| Effect of Special Items on Income Taxes | 1.16 | -1.57 | 4.27 | 100.12 |
| Income Taxes Excluding Impact of Special Items | -48.15 | 11.43 | -349.48 | 35.19 |
| Normalized Income After Taxes | 545.98 | 658.32 | 428.64 | 169.79 |
| Normalized Income Available to Common | 433.29 | 527.54 | 375.55 | 144.66 |
| Basic Normalized EPS | 5.15 | 6.32 | 4.69 | 1.81 |
| Diluted Normalized EPS | 4.52 | 5.78 | 4.40 | 1.81 |
| Amortization of Intangibles, Supplemental | 92.60 | 79.60 | 42.14 | 79.43 |
| Depreciation, Supplemental | 88.40 | 75.36 | 74.27 | 71.68 |
| Interest Expense, Supplemental | 153.56 | 109.33 | 105.30 | 109.11 |
| Rental Expense, Supplemental | -- | 42.00 | 37.90 | 50.80 |
| Stock-Based Compensation, Supplemental | 240.79 | 238.42 | 264.62 | 104.82 |
| Advertising Expense, Supplemental | -- | 1,200.00 | 1,100.00 | 1,000.00 |
| Equity in Affiliates, Supplemental | -- | -- | -- | -- |
| Minority Interest, Supplemental | -112.69 | -130.79 | -53.08 | -25.13 |
| Research & Development Expense, Supplemental | 345.42 | 309.33 | 250.88 | 212.77 |
| Audit-Related Fees, Supplemental | -- | 2.37 | 2.80 | 2.32 |
| Audit-Related Fees | -- | 0.05 | 0.05 | 0.05 |
| Tax Fees, Supplemental | -- | 0.00 | 0.01 | 0.01 |
| All Other Fees Paid to Auditor, Supplemental | -- | -- | -- | -- |
| Gross Margin | 76.30 | 78.63 | 80.32 | 75.93 |
| Operating Margin | 12.22 | 16.09 | 5.33 | -1.38 |
| Pretax Margin | 10.40 | 17.86 | 2.02 | -2.58 |
| Effective Tax Rate | -9.97 | 1.71 | -528.32 | -- |
| Net Profit Margin | 9.06 | 14.49 | 11.12 | -1.31 |
| Normalized EBIT | 584.65 | 593.94 | 188.47 | 242.74 |
| Normalized EBITDA | 765.65 | 748.90 | 304.87 | 393.84 |
| Current Tax - Domestic | -- | 6.34 | -95.64 | 23.34 |
| Current Tax - Foreign | -- | 38.77 | 24.11 | 27.24 |
| Current Tax - Local | -- | 2.57 | 1.96 | 3.66 |
| Current Tax - Total | -- | 47.68 | -69.57 | 54.25 |
| Deferred Tax - Domestic | -- | -21.79 | -254.38 | -100.80 |
| Deferred Tax - Foreign | -- | -13.06 | -1.44 | -8.87 |
| Deferred Tax - Local | -- | 0.17 | -28.36 | -9.52 |
| Deferred Tax - Total | -- | -34.68 | -284.18 | -119.18 |
| Income Tax - Total | -- | 13.00 | -353.75 | -64.93 |
| Defined Contribution Expense - Domestic | -- | 12.90 | 11.10 | -- |
| Defined Contribution Expense - Foreign | -- | 3.40 | 2.50 | -- |
| Total Pension Expense | -- | 16.30 | 13.60 | -- |
In millions of USD (except for per share items)
Data provided by Kaleidoscope.